Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALiAS Trial
ACTRN12618000106235Phase 4Recruiting
- Sponsor
- The University of Sydney
- Start
- Mar 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lithium carbonate in affective disorder, sponsored by The University of Sydney. Primary endpoint: Suicidality severity. Started Mar 2018; status: recruiting.
02
Drugs
lithium carbonate
03
Conditions
affective disorder
Beyond the preview
Go deeper on ACTRN12618000106235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000106235.